Abstract Library

#4598 I ain’t missing you at all – Vanishing extra-abdominal small intestinal neuroendocrine carcinoma metastasis

Introduction: Small intestinal neuroendocrine neoplasms (siNEN) are the most common small bowel malignancy. Almost 50% present with distant metastasis.

Conference:

Presenting Author:

Authors: Corrêa Figueira C, Bento A, Cardoso Gomes C, Oliveira A, Oliveira M,

Keywords: Small intestinal neuroendocrine neoplasm, Small intestinal neuroendocrine carcinoma, Metastatic neuroendocrine disease, Extra-abdominal metastatic disease, Non-hepatic neuroendocrine metastasis,

#2731 177Lu-DOTATATE Plus 166Ho-Radioembolization in Patients with Neuroendocrine Tumours; A Single Center, Prospective, Interventional, Non-Comparative, Open Label, Phase II Study (HEPAR PLuS Study)

Introduction: The liver is the most commonly affected organ in metastatic neuroendocrine disease and is the most incriminating factor for patient survival. Additional treatment of liver disease with radioembolization may improve outcome in NET patients with bulky residual liver disease after PRRT.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author: Braat A

Authors: Braat A, Rutger B, Van Rooij R, Braat M, Wessels F,

Keywords: NET, PRRT, SIRT, Radioembolization, Ho-166, Neuroendocrine tumor,

#1818 Patient Outcomes after Cardiac Surgery for Carcinoid Heart Disease Are Dependant Upon Successful Cytoreductive Multimodal Treatment and Control of Metastatic Neuroendocrine Disease

Introduction: Carcinoid Heart Disease (CHD) as a result of long standing carcinoid syndrome is associated with a poor prognosis due to development of valvular incompetence & right heart failure. Cardiac valve surgery is the main therapeutic option.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Jaber B, Ramsey E, Cowburn P, Tsang G, Armstrong T,

Keywords: Carcinoid heart disease, surgery,

#671 Comparison of the Utility of Biochemical Markers in Predicting the Presence and Severity of Carcinoid Heart Disease

Introduction: Carcinoid heart disease (CHD) is a complication of metastatic neuroendocrine disease and is screened for using echocardiography.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Dobson R, Burgess M, Chadwick C, Vora J, Pritchard M,

Keywords: carcinoid heart, biomarker,

#451 Symptomatic Control of Neuroendocrine Tumors with Everolimus

Introduction: Everolimus prolongs progression-free survival, but previous research has not demonstrated its effect on symptoms.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Bainbridge H, Larbi E, Middleton G,

Keywords: neuroendocrine, carcinoid, everolimus, symptom,